What Factors Determine Treatment Outcome in Aneurysmal Subarachnoid Hemorrhage in the Modern Era? A Post Hoc STASH Analysis
Mario Teo,Mathew R Guilfoyle,Carole Turner,Peter J Kirkpatrick,STASH Collaborators,Carole L Turner,Gordon D Murray,Peter J Hutchinson,Graham Teasdale,A David Mendelow,Keith Muir,Martin Smith,Peter McCabe,Jeremy Pearson,Gary Ford,Andrew Vail,Andrew King,Pippa Tyrrell,Hugh Richards,Simon Bond,Christopher Smith,Elizabeth Warburton,Ming Tseng,Diederik Bulters,Martina Brown,Giles Critchley,Gavin Spurling,Jane Gaylard,Mohsen Javadpour,Paul Eldridge,Lorna Murray,Richard Nelson,Ros Taylor,Sarah Hierons,Bianca Tobin,Kelley Storey,Daniel Walsh,Bejal Mistry,John Aeron-Thomas,Corina Puppo,Mario Papadopoulos,Laura Montague,Peter Gan,Graham Flint,Jennie Hurley,Elizabeth Ronne,Inger Stjernling,Ernest Wang,Ei Leen Cheng,Jing Li Lai,Stuart Ross,Ruth Bellfield,Linetty Mandizvidza,Peter Whitfield,Nicola Persad,Nigel Suttner,Kate McGuigan,Linda Cloughley,Hiren Patel,Andrea Ingham,Kellymarie Shaw,Raghu Vindlacheruvu,Julian Millo,Orlando Warner,Rachel Teal,Francis Bernard,Carol Sirois,Shaban Joshi,Sheila Nyabadza,Joan Grieve,Neil Kitchen,Vanessa Bassan,Philip Rayson,Alexander Zeitlin,Max Findlay,Leeca Sonnema,Brenda Poworoznik,Juan Quintero,Sam Eljamel,Frank Rasulo,Ivan Ng,Bruce Mathew,Jill Grieg,Ricardo Hanel,Alexa Richie,Ian Fleetwood,Elizabeth Reardon-White,Ginger Hampton,Stephen Lewis,Lynn Miralia,Howard Brydon,Holly Maguire,Umang Patel,Helen Sanderson,Kathryn Birchall,Pauline Bayliss,Kevin O'Neill,Tina Sachs,Rupert Kett-White,Leanne Quinn
DOI: https://doi.org/10.1016/j.wneu.2017.05.005
Abstract:Background: The management of aneurysmal subarachnoid hemorrhage (aSAH) has changed dramatically in the last few decades with the publication of a few major studies, including ISAT (International Subarachnoid Aneurysm Trial, the International Cooperative Study on the Timing of Aneurysm Surgery Study). The aim of this study is to analyze the outcome of patients with aSAH based on a contemporary series, identify the risk factors for poor outcome, and focus on patients with good-grade aSAH (to match the ISAT cohort). Methods: Baseline demographic and outcome data (modified Rankin Scale) were available for the 803 patients recruited from the STASH (Simvastatin in Aneurysmal Subarachnoid Haemorrhage) trial for post hoc analysis, using a χ2 test or 2-sample t test. Logistic regression analysis was performed to assess the risk factors for poor outcome at 6 months. Propensity matched analysis comparing coiling and clipping, and subgroup analysis of good-grade patients (World Federation of Neurosurgical Societies grade I-II) were also performed. Results: Logistic regression analysis showed that the treatment modality (i.e., coiling or clipping) was not associated with poor outcome at 6 months (P = 0.839). The risk factors associated with poor outcome at 6 months were poor admission World Federation of Neurosurgical Societies grade (P < 0.0001), Fisher grade on initial computed tomography scan (P = 0.013), and the development of delayed cerebral ischemia (P < 0.0001). Subgroup analysis for good-grade patients only showed that 82% of patients after coiling and 78% of patients after clipping were classed as good outcome at 6 months (P = 0.181). Conclusions: In the current era of aSAH management, apart from patients' admission status, SAH blood load and the development of delayed cerebral ischemia, treatment modality with either coiling or clipping was not associated with poor outcome difference at 6 months.